Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1WAVELENGTH ENTERPRISES LTD. Petah Tikva IL

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

R1-CEP 2007-192 - Rev 08
Valid
Chemical
2023-01-26
1750
Seqens Company Banner

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Certificate Number : R1-CEP 2007-192 - Rev 08

Status : Valid

Issue Date : 2023-01-26

Type : Chemical

Substance Number : 1750

Seqens Company Banner

Looking for Certificates of Suitability (CEPs) for R1-CEP 2007-192 - Rev 08 of Wavelength Enterprises Ltd. Petah Tikva Il

Looking for Certificates of Suitability (CEPs) for R1-CEP 2007-192 - Rev 08 of Wavelength Enterprises Ltd. Petah Tikva Il 1

20

Wavelength Enterprises Ltd. Petah Tikva Il, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

One of their significant offerings is Fluticasone propionate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2007-192 - Rev 08

This Chemical Type CEP, issued on January 26, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 1750 associated with this CEP further emphasizes